ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Compania Energopetrol Sa

Compania Energopetrol Sa (0EC1)

0.00
0.00
(0.00%)
Closed December 05 11:30AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
-
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
-
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
2,025,000
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
782k
Net Profit
-715k

About Compania Energopetrol Sa

Sector
Electrical Work
Industry
Electrical Work
Website
Headquarters
Campina, Rou
Founded
-
Compania Energopetrol Sa is listed in the Electrical Work sector of the London Stock Exchange with ticker 0EC1. The last closing price for Compania Energopetrol was -. Over the last year, Compania Energopetrol shares have traded in a share price range of RON 0.00 to RON 0.00.

Compania Energopetrol currently has 2,025,000 shares outstanding.

0EC1 Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BARBrand Architekts Group Plc
46.70p
(94.58%)
500.53k
CLAICel Ai Plc
0.055p
(56.25%)
108.23M
TBLDTinybuild Inc.
5.65p
(43.04%)
1.21M
SCGLSealand Capital Galaxy Limited
1.10p
(37.50%)
19.94M
GROCGreenroc Strategic Materials Plc
1.95p
(34.48%)
5.89M
ENRGVh Global Energy Infrastructure Plc
66.80p
(-85.72%)
323.26k
EVSTEverest Global Plc
1.40p
(-30.00%)
175k
GFINGfinity Plc
0.035p
(-20.45%)
133.68M
OBDOxford Biodynamics Plc
1.205p
(-19.67%)
4.62M
CARCarclo Plc
31.00p
(-18.21%)
1.55M
ORCPOracle Power Plc
0.0425p
(6.25%)
2.02B
PREMPremier African Minerals Limited
0.0515p
(-11.97%)
912.12M
CLONClontarf Energy Plc
0.0365p
(17.74%)
640.76M
NTVONativo Resources Plc
0.0025p
(0.00%)
513.12M
ROCKRockfire Resources Plc
0.175p
(-16.67%)
491.48M

Discussion

View Full Feed
LCJR LCJR 3 minutes ago
Most don't even know what XRP is, much less know the value. No rug pull here, everyone just needs patience and let it play out.

LCJR

XRPUSD
Info3 Info3 3 minutes ago
In general 
BMXI
misterfishman misterfishman 4 minutes ago
Nice day today.
RDAR
MartinLutherKing MartinLutherKing 4 minutes ago
8. TransCode Therapeutics Announces Safety Review Committee Approval of Second Cohort Opening in Phase 1 TTX-MC138 Clinical Trial Following Favorable Review of Cohort 1 Safety Data
October 23 2024 - 7:00AM

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company co
RNAZ
sluggercjb sluggercjb 4 minutes ago
lol Orca has the Doc. And all shareholders running scared all those threats are keeping everyone up at night. Orca Please stop being a bully lol ..still get a good laugh at his post
VDRM
LCP77 LCP77 4 minutes ago
I meet twice a year with my tax advisor (CPA). Once about now, for year end positioning, and then for tax season. I’ve found that to be worthwhile.
NB
bananarama bananarama 6 minutes ago
Forget about a five dollar BO. After yesterday's Web Conference, that price has already jumped to at least ten dollars. If some white knight waits to buy KBLB, they will be paying twice that amount. GO KBLB!
KBLB
nt2innovate nt2innovate 6 minutes ago
Yes. Good call. Hopefully buying will increase on the OTC with retail and family offices if they start seeing 30-40% annual growth rates going forward without dilution as you said which will cause the stock price to go up significantly.

The idea of the PEC along with Enclave having va
SDCH
northam43 northam43 6 minutes ago
Report # 6.1 SPX Cycles Short Range Chart (60 min & Daily Cycles)

https://investorshub.advfn.com/uimage/uploads/2024/12/5/stiec6.1_Short_Term.png
jsc52033 jsc52033 6 minutes ago
actualy its down 3,397 from yesterday yet yes way ahead of Tueday which was almost none at 150,000 +
BMXI
MartinLutherKing MartinLutherKing 6 minutes ago
6.TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate
September 17 2024 - 7:00AM

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer usin
RNAZ
fwb fwb 7 minutes ago
If it's McDonald NEWS, we could go higher than $20.00
SOUN
XenaLives XenaLives 7 minutes ago
Define "e" as massive AI manipulation of the market as a whole....
AVXL
band aid band aid 7 minutes ago
Does anyone think they will figure out how to sell a few more trinkets then they have in the past. I guess we shall see in the once a year financial reports. Then maybe the company may have a couple of bucks in the bank.
BIEL
northam43 northam43 7 minutes ago
Report # 6.1 SPX Cycles Short Range Chart (60 min & Daily Cycles)

https://investorshub.advfn.com/uimage/uploads/2024/12/5/stiec6.1_Short_Term.png
zab zab 8 minutes ago
The trump clown show is in full display for everyone to see, another reason only 49 percent of America voted for orange shittypants.  But remember trump will blame everyone else for his daily mistakes,  and meltdowns.
MartinLutherKing MartinLutherKing 8 minutes ago
5.TransCode Therapeutics Announces Publication of Study with Lead Therapeutic Candidate Revealing Mechanisms Behind Candidate’s Preclinical Efficacy Against Metastatic Cancer
September 10 2024 - 7:00AM


TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology compan
RNAZ
misterfishman misterfishman 8 minutes ago
There is plenty of frustration going on over here mostly due to impatience peeps this stock is a longterm play like a few years out if peeps can't wait then sell.its that simple.
IGPK
bananarama bananarama 8 minutes ago
I totally agree with you, Monkey! Any company interested in buying KBLB would recognize that it is better to buy the company now rather than wait for it to reach the Texas Exchange (or the NASDQ). Then, the BO price will be MUCH MUCH higher. GO KBLB! ;-)
KBLB
MartinLutherKing MartinLutherKing 9 minutes ago
4.TransCode Therapeutics Awarded $2 Million NIH Grant to Support Clinical Evaluation of Lead Candidate
September 05 2024 - 7:00AM

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today an
RNAZ

Your Recent History

Delayed Upgrade Clock